Oakmark Global Concentrated Strategy adds SNY; exits MBGAF and RHHBY
Source: SeekingAlpha
2026-02-19 12:44:15 ET
More on Sanofi, Mercedes-Benz Group AG, etc.
- Mercedes-Benz Group AG (BENZ:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
- Mercedes-Benz Group AG 2025 Q4 - Results - Earnings Call Presentation
- Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued
- Genentech's Gazyva succeeds in phase 3 trial for primary membranous nephropathy
- Sanofi replaces CEO Paul Hudson, names Belén Garijo as successor
Read the full article on Seeking Alpha
For further details see:
Oakmark Global Concentrated Strategy adds SNY; exits MBGAF and RHHBY
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-2.37% G/L:
$50.70 Last:
1,323,065 Volume:
$51.31 Open:
RHHBY Latest News
March 09, 2026 02:10:00 am
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
